Navigation Links
Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
Date:5/17/2012

CLEVELAND, Ohio, May 17, 2012 /PRNewswire/ --

Simbionix USA Corporation, the world's leading provider of medical simulation, training and education products, is proud to announce the release two new platform designs this week: the new GI Mentor™ Express simulator and the enhanced hardware for the URO Mentor™.

     (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a)


     (Photo: http://photos.prnewswire.com/prnh/20120517/533112 )

The GI Mentor Express is an elegant portable platform offering the most advanced hands-on training in Gastrointestinal Endoscopy. This high end virtual reality trainer offers over 60 tasks and virtual patient cases for endoscopy skill enhancement, colonoscopy, gastroscopy, sigmoidoscopy and gastric bleeding. Just as in the full sized GI Mentor, training on this portable solution is done utilizing an actual scope, realistic tactile sensation and true to life anatomy, physiology and pathologies. All of the mentioned features, together with performance metrics validated in more than 40 studies, contribute to preparing the trainee for performing actual cases on live patients. The GI Mentor Express is offered in several configurations for enhanced flexible pricing. Simbionix will unveil the new GI Express at the DDW in San Diego, CA, May 20-22, booth #3025.

The newly enhanced URO Mentor being launched this week by the company was designed to enable future simulation content on the same platform. Currently the system combines training for both endourology and percutaneous access procedures. The unique cost effective design utilizes the latest technology, and is ready to be upgraded with female urologic anatomy, for future modules and training procedures. The new system will be unveiled at the upcoming AUA in Atlanta, GA, May 19-22, at booth #2761.

Ran Bronstein, Simbionix President and COO, commented that "Simbionix continues to enhance existing products and develop new products in order to provide the best value for our clients. Work on a specific trainer is on-going even after the simulator is released, as we keep on developing new modules and working on the existing configurations and platforms to improve the products and keep them updated with the latest technologies."

About Simbionix USA Corporation

Simbionix is the world's leading provider of medical simulation training and education products for medical professionals and the healthcare industry. The company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

Visit: http://www.simbionix.com  

Follow us on Facebook, Twitter and LinkedIn.

Contact: Rebecca Levy, Manager of Marketing Communications, rebecca@simbionix.com; +1-216-229-2070 #128



'/>"/>
SOURCE Simbionix USA Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
4. Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
5. Simbionix and AABIP Sign Collaboration Agreement
6. McGraw-Hill Professional and Simbionix™ Partner to Provide Enhanced Surgical Simulation and Education
7. Patent Granted for Simbionix Procedure Rehearsal Studio™
8. Simbionix to Introduce Three New Womens Health Products
9. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
10. FDA Cleared New Application for Simbionix PROcedure Rehearsal Studio
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)... 28, 2017  "US Cancer Generics Market Outlook ... indicators and trend analysis related to the emergence ... pharmaceutical market in US. The report analyzes various ... on cancer generics drugs in recent years. The ... billions of dollars for various stake holders involved ...
(Date:3/28/2017)... Therapeutics, Inc. (Nasdaq: OREX ) today announced ... year ended December 31, 2016. "Last ... beginning with the re-acquisition of the rights to Contrave® ... at Orexigen demonstrated remarkable focus, executing on a myriad ... Company while rewarding us full control of our FDA ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... (MRE), is pleased to be invited to the Siemens Healthineers annual customer education ... The event will take place from March 27 - 31, 2017 at ...
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have ... World Travel Trends Report). As travelers visit both urban destinations, they are faced ... prolonged sun exposure. In response, the outdoor industry has blurred the lines between ...
(Date:3/28/2017)... , ... March 28, 2017 ... ... non-profit medical society dedicated to advancing the science and clinical practice of ... its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in ... Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most ... kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with ...
Breaking Medicine News(10 mins):